Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma

BACKGROUND: Ramucirumab (RAM), a monoclonal antibody for vascular endothelial growth factor 2 (VEGFR2), has been effective for advanced gastric adenocarcinoma (AC). However, little is known about the efficacy of RAM-containing chemotherapy (RAM-CTx) in gastric neuroendocrine carcinoma (G-NEC). METHO...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:ESMO Open
Glavni autori: Mishima, Saori, Kawazoe, Akihito, Matsumoto, Hiroshi, Kuboki, Yasutoshi, Bando, Hideaki, Kojima, Takashi, Doi, Toshihiko, Ohtsu, Atsushi, Yoshino, Takayuki, Nonte, Elizabeth M, Chintharlapalli, Sudhakar, Nasir, Aejaz, Kuwata, Takeshi, Shitara, Kohei
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2018
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6212678/
https://ncbi.nlm.nih.gov/pubmed/30425849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000443
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items